The use of potent coagulation factor concentrates has dramatically changed the clinical picture and the life expectancy of haemophiliacs. The aim of well-organized care of haemophiliacs is to prevent not only life-threatening bleeding episodes, but also the development of disabling arthropathies. In spite of numerous effective drugs and the beneficial effect of early synovectomy, haemophilic arthropathy will long remain a crux of everyday practice. Based on 10 years' experience at the National Institute of Haematology and Blood Transfusion, this volume presents a detailed description of the...